Rilotumumab is a human monoclonal antibody designed for the treatment of solid tumors.

Flanvotumab is a human monoclonal antibody designed for the treatment of melanoma.

Fasinumab is a human monoclonal antibody designed for the treatment of pain.

Researchers will inject an antibody designed to hook up to certain infection-fighting white blood cells.

Both products are monoclonal antibodies, designed to bind to a particular target in the body.

The prepared sample is then incubated with a specific antibody designed to bind the molecule of interest.

Dusigitumab is a human monoclonal antibody designed for the treatment of cancer.

Drozitumab is a human monoclonal antibody designed for the treatment of cancers.

Oxelumab is a human monoclonal antibody designed for the treatment of asthma.

Guselkumab is a monoclonal antibody designed for the treatment of psoriasis.